PPT-HIV & HCV through the Medicine Wheel

Our Services Emotional Reactions Feelings about Ourselves amp Others Spiritual Values Self Esteem amp Acceptance Balance amp Connection Physical Physical Health Selfcare of Bodies. John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. Regional Pharmacy Director, NY/NJ AETC. Pharmacist, Albany Medical Center. Objectives. Discuss recent guidelines . changes for HIV infection. Using . patient cases, discuss the role of . HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Trial. Phase . 3. Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Treatment. Naïve and Treatment . Experienced. HIV Coinfection. Source: . Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Prevalence. . among. . People. . Who. . Inject. . Drugs. : . Results. . from. . the. . First. . Integrated. Bio-. behavioral. . Survey. . of. PWID . in. Mozambique. Authors. : . Cynthia SEMÁ-BALTAZAR. Cathryn. L. Samples, MD, MPH, AAHIVS. Director, Boston HAPPENS. Boston Children’s Hospital. Presented at: Improving . Care for Substance Use, HIV and HCV in Adolescents: . Effective Approaches to Assessing, Treating, and Engaging . Co-Infection – Florida, . 2014. . STD and Hepatitis Section in collaboration with HIV/AIDS Section – Surveillance Unit . Division of Disease Control and Health Protection. HIV Disease data from 1981 through December . Presented by: . Fabian Cretu, Beverly-Ann Oliver, Kristina Miclat, Maeryl Sumagang. PHM142. September 25, 2018. PHM142 Fall . 2018. Instructor: . Ms. Maya Latif. Coordinator: Dr. J. Henderson. HIV. . Case. 47-Year-Old . Man With Asymptomatic HIV Infection. Case (cont). Initial Clinical Presentation. Laboratory Results. HepaScore. ®. A Composite Biomarker Panel for Liver Fibrosis. Hepatic Steatosis in Patients With HIV/HCV Coinfection. Isabelle Andrieux-Meyer, MD. Médecins Sans Frontières . IAS Kuala Lumpur, July 2. nd. 2013. . Prevention strategies for HIV/HCV co infection. Epidemiological burden of HCV/HIV co-infection. Access to HCV screening. & HCV . Therapy. Larry Pineda, . PharmD. , . PhC. , BCPS, AAHIVP. Visiting Assistant Professor. UNM College of Pharmacy. Conflicts of Interest Disclosure. No conflicts of interest. 2. Learning Objectives – Pharmacist. Co-Infection – Florida, . 2013. . STD and Hepatitis Section in collaboration with HIV/AIDS Section – Surveillance Unit . Division of Disease Control and Health Protection. HIV Disease data from 1981 through December . Todd S. Wills, MD. Martha Friedrich, PhD. SPNS Hepatitis C Treatment Expansion Initiative. University of South Florida. The HIV/HCV Disease Burden. Hepatitis C. In U.S., 4 million HCV+ . →. 85% chronic . Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017. Available HCV treatment DAAs. Epclusa. (. sofosbuvir. / . velpatasvir. ). Harvoni. (. sofosbuvir. / . ledipasvir. ). Zepatier. (. grazoprevir. / . Presented by: Thomas E. Burgess, PhD, DABCC, FAACC. March 30, 2018. Version 2.0. Hepatitis C Virus. Hepatitis C virus. (. HCV. ) is a small (55–65 . nm. in size) virus. The hepatitis C virus belongs to the genus . & . Update on HCV . blood bank protocol. . Overview - . diagnostic tests. Serologic . assays: . specific antibody to hepatitis C virus (anti-HCV). Molecular . assays: HCV nucleic acid . (. nucleic.